FDA Fast-Tracks Avutometinib and Defactinib Combination for Treatment of KRAS-Mutated Ovarian Cancer
FDA Fast-Tracks Avutometinib and Defactinib Combination for Treatment of KRAS-Mutated Ovarian Cancer
Pune, India | August 21, 2025– The U.S. Food and Drug Administration (FDA) has granted accelerated approval...